Advanced specialty science to accelerate your most complex clinical programs.
Complex assays designed to withstand regulatory scrutiny. Flow cytometry panels harmonized across continents. And scientific decisions that can’t wait for vendor delays.
Your most ambitious research requires laboratory partners who understand these challenges.
At Cerba Research, we unite deep scientific expertise with cutting-edge technology to support critical decision-making from discovery through commercialization. With 14 specialty laboratories across five continents and the strength of a global central laboratory network, we deliver customized solutions at scale without compromising precision or rigor.
Modern oncology and immunology trials demand expert pathology interpretation. From PD-L1 expression to multiplex tumor microenvironment analysis, histopathology and IHC provide critical tissue-based insights that guide precision medicine. Our global network of board-certified pathologists and state-of-the-art platforms ensures consistent, reproducible results across your trial sites.
From companion diagnostics to exploratory biomarkers, we provide the histopathology expertise that transforms tissue samples into actionable clinical insights.
14 specialty laboratories across five continents with advanced technology platforms and therapeutic area expertise
Specialized expertise where complexity meets innovation.
From sample to insight: comprehensive specialty testing capabilities.
Every cell therapy program faces complex analytical hurdles, from monitoring CAR-T persistence across diverse patient populations to validating vector copy numbers with regulatory confidence.
Cell and gene therapies require highly specialized laboratory expertise at every stage of development. This guide outlines proven analytical strategies that have supported 50+ CGT trials and 5 market authorizations, including 3 CAR-T therapies.
What you’ll discover in our guide:
Our specialist scientists work with you from protocol design to optimize biomarker strategies, develop fit-for-purpose assays, and leverage proven methodologies from hundreds of successful trials. From histopathology validation to complex flow panels, early scientific consultation ensures your testing strategy aligns with regulatory expectations.
When your trial needs both advanced biomarker testing and routine safety monitoring, our integrated platform removes the need for multiple vendors. One partner. One quality system. Seamless data. Our global central laboratory network delivers routine and specialty testing through a single, unified workflow.
14 specialty laboratories backed by deep expertise in oncology, infectious diseases, cell & gene therapy, and immunology. Harmonized SOPs and centralized scientific oversight ensure consistent excellence across continents. Our technology breadth, from IHC to NGS to AAV testing, means you never compromise on capability.
Our accreditations span continents and therapeutic areas, ensuring your specialty testing meets the highest international standards for regulatory submission across global markets.
